Ark

3 known investors

Ark applies machine learning and AI to bioprocessing, replacing trial-and-error methods with hybrid predictive models to accelerate drug development and scale biotherapeutic manufacturing. The platform serves biopharmaceutical companies and biotech firms seeking to reduce R&D timelines and production costs.

AI & Machine LearningBiotechSaaS